Abstract:Introduction: Regulatory T cells (Treg) have been shown to prevent allograft rejection and plays an important role in promote donorspecific antigenic tolerance in solid organ transplantation. In this study, we analyzed the ratio of CD4+CD25+Foxp3+/Th17 T cell in the peripheral blood of kidney recipients with living-related donor in different immunosuppressive therapy, and analyzed the relationship between the ratio of CD4+CD25+Foxp3+/Th17 T cell and patients who have long-term survival. Methods: The study was approved by the local ethical committee. Twelve renal transplant recipients with living-related donor received combined donor-specific blood transfusion and kidney transplantation more than six years were enrolled, and ten healthy volunteers as healthy control (HC). Posttransplant patients were divided into two groups depending on their immunosuppressive therapy: calcineurin inhibitors (CNI) and rapamycin (Rapa). Analyzed the expression of CD4+CD25+Foxp3+T cells and Th17 T cells in the peripheral blood under the stimulate condition (phorbol myfismte acetate and ionomycin) and no-stimulate condition for all objects by flow cytometry, and the mixed lymphocyte reaction (MLR) in recipient with their donors and independent third party by methyl thiazolyl tetrazolium (MTT). Results: The proportion of CD4+CD25+Foxp3+ T cells in the peripheral blood under the stimulate condition and no-stimulate condition in group of Rapa were 2.24% and 2.14%, respectively, significant higher than group of CNI (P< 0.05, Table 1), and, there was no significant difference for the proportion of Th17 T cells between the group of Rapa and CNI. The ratio of CD4+CD25+Foxp3+/Th17 T cells in group of Rapa under the stimulate condition and no-stimulate condition were 3.42 and 8.92, respectively, significant higher than group of CNI (P< 0.05, Table 1). In all groups, the result of MLR with independent third party higher than their donors, and the MLR with independent third party in group of Rapa was higher than group of CNI.[Table 1 The expression of Treg and Th17 T cells]Conclusion: This study showed in living-related donor kidney recipients who received combined donor-specific blood transfusion and kidney transplantation obtain better long-term graft and patient survival. Increased numbers of CD4+CD25+Foxp3+ T cells and the ratio of CD4+CD25+Foxp3+/Th17 T cells and higher MLR with independent third party in group of Rapa compared with group of CNI. Therefore, monitoring of Treg in the peripheral blood as a biomarker of tolerance may detect unresponsiveness to the graft.

Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients

Gut Microbes Enlarged the Protective Effect of Transplanted Regulatory B Cells on Rejection of Cardiac Allografts.

Phase I trial of donor-derived modified immune cell infusion in kidney transplantation

Alteration Of Innate Immunity By Donor Il-6 Deficiency In A Presensitized Heart Transplant Model

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

Rise of a CD27− IgD− CD11c+ B cells population in kidney recipients achieving long‐term graft stability under immunosuppression

The Mixed Lymphocyte Reaction and the Ratio of Cd4(+)Cd25(+)Foxp3(+)/Th17 T Cell in Long Term Graft and Recipents Survival of Kidney Transplantation with Living-Related Donor

Abo-Incompatible Living Kidney Transplantation

Single-Cell Transcriptomic Analysis of Peripheral Blood Reveals a Novel B-Cell Subset in Renal Allograft Recipients With Accommodation

Induction Tolerance with Donor Hematopoietic Stem Cell Infusion in Kidney Transplantation: a Single-Center Experience in China with 10-Year Follow-Up

Tolerance Induction with Donor Hematopoietic Stem Cell Infusion in Kidney Transplantation: a Single-Center Experience in China with a 10-Year Follow-Up

Renal Transplantationplus Hematopoietic Stem Cell Transplantation As Induction Therapy :A Single-Center 10-Year Experience

THE FEATURE OF MDSCS IN THE LONG-TERM STABLE KIDNEY TRANSPLANT RECIPIENTS AFTER DIFFERENT IMMUNOSUPPRESSION THERAPY

Transfer of Regulatory T Cells Generated Ex Vivo Modifies Graft Rejection Through Induction of Tolerogenic CD4+CD25+ Cells in the Recipient

IL-10-producing memory B regulatory cells as a novel target for HLA-G to prolong human kidney allograft survival

Immune Cell Alterations and Association with Clinical and Laboratory Parameters

Regulatory B Cells in Solid Organ Transplantation: From Immune Monitoring to Immunotherapy

Glycolysis Changes in Alloreactive Memory B Cells in Highly Sensitized Kidney Transplant Recipients Undergonig Desensitization Therapy

Evaluation of Regulatory B Cell Subpopulations CD24++CD38++, CD24++CD27+, Plasmablasts and Their Correlation with T Regs CD3+CD4+CD25+FOXP3+ in Dialysis Patients and Early Post-Transplant Rejection-Free Kidney Recipients

Regulatory-B Cell and Regulatory-T Cell Collaborate to Promote Transplantation Tolerance (126.2)

Porcine anti-human lymphocyte immunoglobulin depletes the lymphocyte population to promote successful kidney transplantation